• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

9.890 -0.120 (-1.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,853,832
Open 10.03
Bid (Size) 9.630 (200)
Ask (Size) 10.20 (200)
Prev. Close 10.01
Today's Range 9.830 - 10.30
52wk Range 4.720 - 13.74
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why NeoGenomics (NEO) Shares Are Falling Today
February 18, 2026
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 10.1% in the afternoon session after the company reported fourth-quarter results that beat expectations but issued a... 
Via StockStory
Topics Artificial Intelligence
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
February 18, 2026
From NeoGenomics, Inc.
Via Business Wire

Performance

YTD
-15.9%
-15.9%
1 Month
-22.1%
-22.1%
3 Month
-13.9%
-13.9%
6 Month
+49.7%
+49.7%
1 Year
-16.6%
-16.6%

More News

Read More
News headline image
NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook
February 18, 2026
Via StockStory
News headline image
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics Earnings
NeoGenomics Inc (NASDAQ:NEO) Beats Q4 Earnings Estimates and Provides 2026 Guidance ↗
February 17, 2026
Via Chartmill
News headline image
NeoGenomics’s (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates
February 17, 2026
Via StockStory
Topics Earnings
News headline image
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
February 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For
February 15, 2026
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
February 12, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
1 Stock Under $50 Worth Your Attention and 2 We Brush Off
February 08, 2026
Via StockStory
News headline image
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 27, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Cash-Burning Stocks with Warning Signs
January 18, 2026
Via StockStory
Topics Electric Vehicles
News headline image
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
January 12, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
December 30, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Russell 2000 Stocks We Think Twice About
December 17, 2025
Via StockStory
News headline image
3 Stocks Under $50 We Steer Clear Of
December 16, 2025
Via StockStory
News headline image
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
December 15, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New ctDNA Research at SABCS 2025
December 10, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
December 08, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
December 05, 2025
Via StockStory
News headline image
3 Overrated Stocks That Concern Us
December 03, 2025
Via StockStory
News headline image
1 Cash-Burning Stock to Research Further and 2 We Brush Off
November 25, 2025
Via StockStory
Topics Retirement
News headline image
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know
November 21, 2025
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
November 16, 2025
Via StockStory

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 9.890
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.21B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap